電子処方箋市場の規模、シェア、成長分析、製品タイプ別、配信モード別、エンドユーザー別、使用方法別、物質別、専門分野別、地域別 - 産業予測、2025～2032年

電子処方箋の世界市場規模は、2023年に36億6,000万米ドルと評価され、2024年の46億4,000万米ドルから2032年には310億1,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは26.8％で成長する見通しです。

処方ミスは、ヘルスケア現場で報告される薬剤関連事故の72％以上を占め、世界中の医療従事者に重大な懸念をもたらしています。このようなミスが死亡事故につながることはまれですが、患者に深刻な健康リスクをもたらし、ヘルスケア専門家に対する法的措置につながることも少なくありません。この問題に対処するため、電子処方（e-prescribing）が効果的な解決策として浮上しています。この技術により、医療従事者は処方箋を電子的に薬局に送ることができ、薬物相互作用を最小限に抑え、ミスを減らすことで患者の安全性を高めることができます。さらに、e-prescribingは従来の方法よりも費用対効果が高く効率的な代替手段を提供し、処方プロセスを合理化します。様々な医療施設で電子処方システムの採用が予想されるのは、医療の質を高める上でこの技術に対する需要が高まっていることを示しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 技術の進歩
• 規制情勢
• スタートアップ分析
• 特許分析

電子処方箋市場規模：製品タイプ別

• 市場概要
• ソリューション
  • 統合ソリューション
  • スタンドアロンソリューション
• サービス
  • 実装サービス
  • サポートおよびメンテナンスサービス
  • トレーニングおよび教育サービス

電子処方箋市場規模：配信モード別

• 市場概要
• ウェブベース
• クラウドベース
• オンプレミス

電子処方箋市場規模：エンドユーザー別

• 市場概要
• 病院
• クリニック
• 薬局
• 外来手術センター
• その他

電子処方箋市場規模：使用方法別

• 市場概要
• ハンドヘルド
• コンピュータベースのデバイス

電子処方箋市場規模：物質別

• 市場概要
• 規制物質
• 規制対象外物質

電子処方箋市場規模：専門分野別

• 市場概要
• 腫瘍学
• スポーツ医学
• 神経学
• 心臓病学
• その他

電子処方箋市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• CVS Health Corporation（United States）
• Giant Eagle Inc.（United States）
• Lloyds Pharmacy Limited（United Kingdom）
• Rowland Pharmacy（United Kingdom）
• The Kroger Co.（United States）
• Walmart Inc.（United States）
• Cerner Corporation（United States）
• Allscripts Healthcare Solutions, Inc.（United States）
• McKesson Corporation（United States）
• Athenahealth, Inc.（United States）
• Medtronic plc（Ireland）
• Siemens Healthineers AG（Germany）
• GE Healthcare（United States）
• Philips Healthcare（Netherlands）
• IBM Watson Health（United States）
• Oracle Corporation（United States）

結論と推奨事項

Global E-Prescription Market size was valued at USD 3.66 billion in 2023 and is poised to grow from USD 4.64 billion in 2024 to USD 31.01 billion by 2032, growing at a CAGR of 26.8% during the forecast period (2025-2032).

Prescription errors represent over 72% of drug-related incidents reported in healthcare settings, raising significant concerns for medical practitioners globally. While these mistakes rarely lead to fatalities, they pose serious health risks for patients and often result in legal actions against healthcare professionals. To combat this issue, electronic prescribing (e-prescribing) has emerged as an effective solution. This technology allows medical providers to electronically send prescriptions to pharmacies, enhancing patient safety by minimizing drug interactions and reducing errors. Additionally, e-prescribing offers a more cost-effective and efficient alternative to traditional methods, streamlining the prescription process. The anticipated growth in the adoption of e-prescribing systems across various medical facilities indicates a rising demand for this technology in enhancing the quality of care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global E-Prescription market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global E-Prescription Market Segmental Analysis

Global E-Prescription Market is segmented by Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties and region. Based on Product Type, the market is segmented into Solutions and Services. Based on Delivery Mode, the market is segmented into Web-based, Cloud-based and On-premise. Based on End-User, the market is segmented into Hospitals, Clinics, Pharmacies, Ambulatory Surgical Centers and Others. Based on Usage Methods, the market is segmented into Handheld and Computer Based Devices. Based on Substances, the market is segmented into Controlled Substances and Non-controlled Substances. Based on Specialties, the market is segmented into Oncology, Sports Medicine, Neurology, Cardiology and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global E-Prescription Market

One of the key drivers of the global e-prescription market is the growing emphasis on eliminating adverse drug events (ADEs) and reducing medical errors in healthcare. Medication mistakes can significantly compromise patient health, making it essential for healthcare providers to utilize robust e-prescribing systems. These systems enable clinicians to access comprehensive patient records, including medical histories, current medications, and diagnoses, thereby enhancing patient safety and minimizing the likelihood of errors. As the incidence of medication errors and drug-related side effects continues to escalate worldwide, the demand for e-prescribing solutions is expected to surge, further propelling market growth.

Restraints in the Global E-Prescription Market

The global e-prescription market faces significant restraints, primarily due to the high expenses associated with the implementation and maintenance of integrated e-prescribing systems. Even though these systems are gaining traction in various clinical environments, their steep costs deter broader acceptance, particularly in developing regions where financial resources are limited. Moreover, the absence of adequate healthcare IT infrastructure in many emerging economies further hinders the growth of this market. As a result, the combination of high investment requirements and insufficient support systems poses a considerable challenge to the widespread adoption of e-prescribing solutions across the globe.

Market Trends of the Global E-Prescription Market

The global e-prescription market is poised for significant growth, driven by the integration of e-prescribing software with Electronic Health Record (EHR) systems. This integration provides numerous advantages, including access to clinical notes, laboratory data, and clinical decision support tools, which standalone systems lack. By enhancing patient medication histories and pharmacy benefits information, EHR-connected e-prescriptions make critical drug data readily available, thereby reducing prescription errors in community healthcare settings. Additionally, increasing government initiatives to implement integrated EHR systems in hospitals further propel market expansion, highlighting the crucial role of technology in improving patient safety and healthcare efficiency.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Startup Analysis
• Patent Analysis

Global E-Prescription Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Solutions
  • Integrated Solutions
  • Standalone Solutions
• Services
  • Implementation Services
  • Support & Maintenance Services
  • Training & Education Services

Global E-Prescription Market Size by Delivery Mode & CAGR (2025-2032)

• Market Overview
• Web-based
• Cloud-based
• On-premise

Global E-Prescription Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Pharmacies
• Ambulatory Surgical Centers
• Others

Global E-Prescription Market Size by Usage Methods & CAGR (2025-2032)

• Market Overview
• Handheld
• Computer Based Devices

Global E-Prescription Market Size by Substances & CAGR (2025-2032)

• Market Overview
• Controlled Substances
• Non-controlled Substances

Global E-Prescription Market Size by Specialties & CAGR (2025-2032)

• Market Overview
• Oncology
• Sports Medicine
• Neurology
• Cardiology
• Others

Global E-Prescription Market Size & CAGR (2025-2032)

• North America (Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties)
  • US
  • Canada
• Europe (Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CVS Health Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Giant Eagle Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lloyds Pharmacy Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rowland Pharmacy (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Kroger Co. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Walmart Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allscripts Healthcare Solutions, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Athenahealth, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM Watson Health (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations